Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Vertex Announce Licensing Agreement And Collaboration With Treefrog Therapeutics To Optimize Production Of Vertex's Cell Therapies For Type 1 Diabetes

Author: Benzinga Newsdesk | April 23, 2024 01:37am

Vertex obtains an exclusive license to TreeFrog's C-StemTM manufacturing technology in type 1 diabetes
TreeFrog and Vertex to collaborate on scale-up of fully differentiated, insulin-producing pancreatic islet cells

Posted In: VRTX